- Better Plant Sciences Inc. announced the common shares of its partially owned subsidiary NeonMind Biosciences Inc. are now approved for trading on the Canadian Securities Exchange as a new listing under the stock ticker symbol “NEON”.
- NeonMind expects to close its fully subscribed Initial Public Offering on December 30, 2020 and commence trading on the Exchange under the symbol “NEON” on Monday, January 4, 2021.
Better Plant Sciences Inc. (PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) announces the common shares of its partially owned subsidiary NeonMind Biosciences Inc. (“NeonMind“) are now approved for trading on the Canadian Securities Exchange (the “Exchange”) as a new listing under the stock ticker symbol “NEON”. NeonMind expects to close its fully subscribed Initial Public Offering on December 30, 2020 and commence trading on the Exchange under the symbol “NEON” on Monday, January 4, 2021.
The listing of NeonMind on the Exchange will not affect the listing of Better Plant and Better Plant’s common stock will continue to trade on the Exchange under the ticker symbol “PLNT”, and continue to trade on the OTCQB under the ticker symbol “VEGGF”. Better Plant owns 33,313,500 common shares in NeonMind, which are subject to an escrow agreement which releases the shares for transfer in tranches over a 3 year period, in accordance with National Policy 46-201.
More information on NeonMind and the NeonMind IPO can be found in NeonMind’s final prospectus which is available on SEDAR at www.sedar.com under issuer information for NeonMind Biosciences Inc.
About NeonMind Biosciences Inc.
NeonMind plans to help people change their lives by changing their minds, through treatment with psychedelics. It is tackling one of the biggest health issues the world is facing right now: obesity. It’s an epidemic that is responsible for 37% of the global burden of disease, according to the World Health Organization. NeonMind is engaged in research to develop a patent pending treatment using psilocybin (a complex organic compound found in psychedelic mushrooms) to cause weight loss. It commenced a Preclinical Trial in November 2020 at the University of British Columbia after Health Canada granted authorization to the Principal Investigator to use psilocybin for NeonMind’s Preclinical Trial.
NeonMind has filed 5 US provisional patent applications claiming methods of aiding in weight loss, treating compulsive eating disorder, treating obesity or a complication of obesity, and/or altering the diet of an individual by administering psilocybin and/or other psychedelic compounds or their analogs or by administering psilocybin or its analog in conjunction with therapy or other treatments.
NeonMind has also commercialized a collection of 4 coffees infused with medicinal mushrooms Lion’s Mane, Turkey Tail, Reishi and Cordyceps, which are available for purchase in Canada at www.neonmind.com.
About Better Plant Sciences Inc.
Better Plant offers a collection of high-efficacy, plant-based products for optimum health and wellness. It creates formulations with the highest quality, natural raw ingredients, combining modern science with nature to create highly-effective, results-driven products for the mind, body and home.
It is a vertically-integrated company with a team whose complementary experience enables acquisition, development, manufacturing, and direct-to-consumer distribution of its products. Better Plant is committed to staying at the forefront of plant-science research and development, and is constantly engaged in research to further expand its portfolio of over 400 proprietary formulations and over 70 SKUs which are currently for sale. Its all natural formulas are designed for health optimization, all without chemicals or harmful ingredients. Better Plant also supports and develops companies with products or services that can help create a better planet, with healthier and happier people. Its minority owned subsidiary NeonMind Biosciences is developing treatments with psychedelics and has commercialized a line of plant-based coffees infused with health optimizing medicinal mushrooms which are for sale at www.neonmind.com. Better Plant operates the direct to consumer platforms www.getjusu.com and www.urbanjuve.com.
Investor Relations Contact:
Penny White, President & CEO
Ali Dumanski, Director of Investor Relations
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.